<code id='30D651E913'></code><style id='30D651E913'></style>
      • <acronym id='30D651E913'></acronym>
      <center id='30D651E913'><center id='30D651E913'><tfoot id='30D651E913'></tfoot></center><abbr id='30D651E913'><dir id='30D651E913'><tfoot id='30D651E913'></tfoot><noframes id='30D651E913'>
      • <optgroup id='30D651E913'><strike id='30D651E913'><sup id='30D651E913'></sup></strike><code id='30D651E913'></code></optgroup>
        5. <b id='30D651E913'><label id='30D651E913'><select id='30D651E913'><dt id='30D651E913'><span id='30D651E913'></span></dt></select></label></b><u id='30D651E913'></u>
          <i id='30D651E913'><strike id='30D651E913'><tt id='30D651E913'><pre id='30D651E913'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-09-28 02:14:13 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：1
                                  
                                    
          
                                   
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan.																									Courtesy Secrist family 
          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.
          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 
          advertisement
          “Oh, crap,” Secrist said to herself.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Testing for cancer recurrence creates a new limbo for patients
                                
                            
          Next article：  
                                      
                                          How to save PrEP access — and even expand it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles